| Literature DB >> 31328038 |
Wen Liao1,2, Lin Xu2, Kaijuan Wangrao2, Yu Du2, Qiuchan Xiong2,3, Yang Yao2,3.
Abstract
With the development of technology, tissue engineering (TE) has been widely applied in the medical field. In recent years, due to its accuracy and the demands of solid freeform fabrication in TE, three-dimensional printing, also known as additive manufacturing (AM), has been applied for biological scaffold fabrication in craniofacial and dental regeneration. In this review, we have compared several types of AM techniques and summarized their advantages and limitations. The range of printable materials used in craniofacial and dental tissue includes all the biomaterials. Thus, basic and clinical studies were discussed in this review to present the application of AM techniques in craniofacial and dental tissue and their advances during these years, which might provide information for further AM studies in craniofacial and dental TE.Entities:
Keywords: Additive manufacturing; Biological scaffold; Craniofacial tissue; Dental tissue; Tissue engineering
Year: 2019 PMID: 31328038 PMCID: PMC6622164 DOI: 10.7717/peerj.7271
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Four kinds of typical AM printers.
(A) Schematic of SLS. The fabrication chamber is settled at the base, filling with tightly compacted plastic powder. When the laser beam moves under the guidance of the scanner system and computer code, precisely shaped monolayer is printed by causing the temperature to rise above the melting point of plastic powder. (B) Schematic of SLA. A computer-controlled laser beam moves and cures the top liquid resin by photopolymerisation. The polymerized resin will adhere to a building platform for support. After finishing the first layer, the building platform drops a defined distance under the liquid surface and the laser repeats the above steps to cure a second layer. (C) Schematic of FFF. Thermoplastic polymeric filament is extruded as the “ink” from a high temperature nozzle (typically 95 °C–230 °C) because of a solid-semiliquid state transition. After printing the pattern of the first layer on a surface, either the nozzle rises, or the platform descends in the Z-axis direction at a thickness of a mono by the control of computer. The process is repeated until structure generation is complete. (D) Schematic of binder jetting: Liquid binder is printed as ink onto powder container. Then a new consecutive solid thin layer of free powder will be put on the binder. This printing process repeats until finishing the work.
Figure 2Chart of the different working steps done in this investigation.
Chart of the different working steps done in this investigation. (A–C) Fabrication of the scaffolds. (D–F) cell cultivation. (G–I) implantation of cell-loaded scaffolds and healing. Histology of bone regeneration 3 days after implantation (arrows mark regions of mineralized matrix; original magnification X10) (J). Defect site 30 days post implantation (arrows mark regions of mineralized matrix; original magnification X10) (K). © Springer (Meyer, Neunzehn & Wiesmann, 2012).
Comparison of various printed bone scaffolds in several in vitro and in vivo studies.
| HA | DP+ Sintered | In vitro | MC3T3-E1 | 7 days | The cells proliferated deep into the structure forming close contact HA granules. | |
| PCL | SLS | In vitro In vivo | BMP7 transduced HGF, Mice | 4 weeks | SLS printed PCL scaffolds enhance bone tissue in-growth. | |
| PEGDMA | SLA | In vitro | Acryl-PEG-RGD | 24 h | Heparan sulfate allows efficient cell attachment and spatial localization of growth factors. | |
| PEGDMA | SLA | In vitro | Human dermal fibroblasts | 24 h | Cell viability reaches at least 87% at 2 h and 24 h following fabrication. | |
| epoxy resin (SL, 7560, Huntsman); CPC(scaffold) | SLA | In vitro | OB | 7 days | Negative molds were generated by SLA. Cell density increased. | |
| TCP/TTCP | 3DP, Sintered, polymer infiltration | In vitro | MC3T3-E1 | 3 weeks | Objects with high compression strengths are obtained without sintering. Cell proliferation and osteogenic differentiation are achieved. | |
| SLS | In vivo | Rabbit tibiae | 4 weeks | Bone was seen to have grown into the porous structure of the laser-sintered parts. | ||
| Bioceramic | 3DP | In vivo | 12 adult Dutch milk goats | 12 weeks | Bone formation within the channels of both monetite and brushite, indicate osteoinductivity of the materials. | |
| PPF/DEF | SLA | In vitro | Fibroblasts | 1 week | Cells were adhering to and had proliferated at the top surface of the scaffold. | |
| Polymer (NG) | FDM | In vivo | Femoral condyles (animal NG) | 5 months | Biomimetic porous design largely enhances bone ingrowth. | |
| PPF/DEF | SLA | In vitro | MC3T3-E1 | 2 weeks | MC3T3 pre-osteoblast compatibility with PPF/DEF scaffolds is greatly enhanced with biomimetic apatite coating | |
| photosensitive hydrogel (Lutrol) | Hydrogel extrusion, UV | In vitro | MSCs | 3 weeks | MSCs embedded in photopolymerizable Lutrol-TP gels remain viable of 60% and keep potential of osteogenic differentiation. | |
| PLGA/PVA | 3DP | In vitro | Human Osteoblasts CRL-11372 | 3 weeks | Expression of ALP and osteonectin remain stable whilst collagen type I and osteopontin decrease. | |
| PLGA/PVA | 3DP | In vivo | Rabbit: 1 intra-periosteum model. 2 bone defect of Ilium. | 24 weeks | In both models, the implanted scaffolds facilitated new bone tissue formation and maturation. | |
| Customized Ca–P/PHBV | SLS | In vitro | SaOS-2, C3H10T1/2 cells | 3 weeks | Affinity of rhBMP2 on immobilized heparin facilitated the osteogenic differentiation of C3H10T1/2 cells during the whole period. | |
| TCP, HAP | 3DP+ Sintered | In vitro | Primary human osteoblasts. | 1 week | Superior biocompatibility of HAP scaffolds to BioOss@ is proved, while BioOss@ is more compatible than TCP. | |
| poly(D,L-lactide) resin | SLA | In vitro | MC3T3 | 11 days | Pre-osteoblasts showed good adherence to these photo-crosslinked networks. | |
| HA, TCP, HA/TCP | 3DP | In vitro | RAW 264.7 cell line | 21 days The results show that osteoclast-like cells were able to resorb calcium phosphate surfaces consisting of granules. | ||
| Torres et al. (2011) | b-TCP powder | 3DP | In vivo | Rabbit calvaria vertical bone augmentation | 8 weeks | Synthetic onlay blocks achieve vertical bone augmentations as as high as 4.0 mm. |
| biphasic calcium phosphate (BCP) | 3DP + Sintered | In vitro | OB BMSC | 3 weeks, 6 weeks | Application of a bioreactor system increases the proliferation and differentiation potential | |
| PDLLA 3-FAME/NVP | SLA | In vitro | MC3T3 | NG | Mouse preosteoblasts readily attach and spread onto porous structures with the well-defined gyroid architectures by SLA. | |
| PCL/bioactive glass(BAG), PLA | FDM | In vitro | Fibroblasts | 2 weeks | FDM printed PLA has better cell friendly surface than PCL and PCL/BAG. | |
| PLGA TCP PPF HA TyrPC MCA | 3DP VS SLA VS PL VS CM | In vivo | Canine Femoral Multi-Defect Model | 4 weeks | TyrPCPL/TCP and PPF4SLA/HAPLGA Dip are better in biocompatibility than PLGA and PLCL scaffolds. MCA remains the best. | |
| biogenic polyphosphate (bio-polyP) and biogenic silica (bio-silica) | SFF/ indirect 3DP/ direct 3DP | In vitro | SaOS-2 cells, RAW 264.7 cells | 10 days | Bio-silica ans bio-polyP increase release of BMP2 while bio-polyP inhibits osteoclasts activity. | |
| PCL | SLS | In vitro | hPDCs | 2 weeks | The double protein coating increased cell metabolic activity and cell differentiation | |
| SLS | In vitro | MG-63 | 5 days, 4 weeks | The mechanical and biological properties of the scaffolds were improved by doping of zinc oxide (ZnO). | ||
| nano-HAP | SLS(NTSS) | In vitro | MG-63 | 5 days | Cells adhered and spread well on the scaffolds. A bone-like apatite layer formed. | |
| PCL | FDM | In vitro | hASCs | 18 days | ASCs seeded on the PCL scaffold are successfully induced in to both vascular and osteogenic differentiation. | |
| PCL/PLGA | FDM | In vitro in vivo | hTMSCs Rabbit radius defect | 4 weeks 8 weeks | PCL/PLGA/collagen released rhBMP2 over one month in vitro, induced the osteogenic differentiation of hTMSCs in vitro and accelerated the new bone formation in the 20-mm rabbit radius defect. | |
| Calcium phosphonate powder CPS | 3DP | In vitro In vivo | C3H/10T1/2 cells, Murine critical size femoral defect. | 9 weeks | 3D printed CPS are enhanced through alternative binder solution formulations. Tween improve the flexural strength of CPS.Implants are osteoconductive. | |
| PCL/PLGA ECM | FDM | In vitro In vivo | hTMSCs, Rat calvarial defect. | 8 weeks | The differentiation and mineralization may be augmented by combined effect of cell-laid extracellular matrix, exogenous osteogenic factors, and flow-induced shear stress |
Figure 3Image-based design allowing creation of defect site- specific scaffolds.
The revised legend: Image-based design allowing creation of defect site-specific scaffolds. The patient image (A) is used in conjunction with appropriate microstructure architecture to create the design for the implant (B). This design can then be produced using solid free-form fabrication, as in this prototype constructed from a single polymeric material (C). Scaffolds were demineralized prior to sectioning, resulting in empty areas (marked with *) that were previously occupied by HA. Safranin O and fast green staining showed a large area of pink-stained cartilage (arrow) in the polymer sponge, in contact with the green–brown-stained bone that formed in the ceramic phase (E). Small pockets of cartilage were also observed within the pores of the ceramic phase of the scaffold (E, arrow). Hematoxylin and eosin staining of the ceramic phase showed the formation of bone (F, arrow) with marrow space within the pores of the HA. The assembled composite: the upper polymer phase (white) and the lower ceramic phase (blue) are transversed by the two PLA struts, one of which is visible on the front of the construct (G). © John Wiley & Sons (Schek et al., 2005).
Comparison of various printed cartilage scaffolds in several in vitro and in vivo studies.
| PCL (NaOH treated) | FDM | In vitro | hOB(iliac crest) hChondrocytes (rib cartilage) | 50 days | Osteogenic and chondrogenic cells can grow, proliferate, distribute, and produce extracellu-lar matrix in these PCL scaffolds. | |
| PCL | SLS | In vivo | Yucatan minipig mandibles | 3 months | Cartilaginous tissue regeneration along the articulating surface with exuberant osseous tissue formation. | |
| PLGA (type II collagen) | FDM | In vitro | Chondrocytes (condyles of Yorkshire pigs) | 4 weeks | Scaffolds swell slightly. The cartilaginous tissue formation was observed around but not yet in the interior of the constructs. | |
| PLGA (lyophilized for 48 h) | LFDM | In vitro | Chondrocytes (condyles of Yorkshire pigs) | 4 weeks | Decrease swelling significantly. Mechanical strength is closer to native articular cartilage. Proliferate well and secret abundant ECM. | |
| ZPR PEG | SLA | In vitro | hMSCs | 1 week | Zero Poisson‘s ratio (ZPR) material PEG has been printed to generate 3D printed scaffolds. The hMSCs adhere and proliferate well. | |
| GelMA | SLA | In vitro Ex vivo | human avascular zone meniscus cells; Human meniscus ex vivo repair model | 6 weeks | Micropatterned GelMA scaffolds are non-toxic, produce organized cellular alignment, and promote meniscus-like tissue formation. | |
| Alginate, silicon, (AgNP infused) | syringe extrusion | In vitro | Chondrocytes (articular cartilage of calves) | 10 weeks | The ears are cultured in vitro for 10 weeks. Audio signals are received by the bionic ears. | |
| PCL, hyaluronic acid, gelatin | SLS | In vitro | Chondrocytes (New Zealand white rabbit) | 4 weeks | This study successfully forms a soft/hard bi-phase scaffold, which offers a better environment for producing more proteins. | |
| PCL, FN, Collagen | Inkjet, Electrospun | In vitro In vivo | Rabbit elastic chondrocytes; Immunodeficient mice subcutaneous model | 8 weeks | The hybrid electrospinning/inkjet printing technique simplifies production of complex tissues. | |
| PTMC | SLA | In vitro | Bovine chondrocytes | 6 weeks | The compression moduli of the constructed cartilage increases 50% to approximately 100 kPa. | |
| PEG | Inkjet, UV | In vitro | human chondrocytes | 4 weeks | Printed neocartilage demonstrated excellent glycosaminoglycan (GAG) and collagen II production with consistented gene expression. | |
| dECM, PCL | Extrusion, FDM | In vitro | hASCs hTMSCs | 2 weeks | Tissue-specific dECM bioinks achieve high cell viability and functionality. | |
| PCL (coating with collagne) | SLS | In vivo | Subdermally dorsal model of female nude mice | 8 week | Collagen as a surface modification material is superior to gelatin in supporting cells growth and stimulating ECM protein secretion. | |
| PCL | FDM | In vivo | Rabbit half-pipe-shaped tracheal defect. Rabbit MSCs | 8 weeks | The 3DP scaffold with fibrin/MSCs served as a resorbable, chondro-productive, and proper cartilage regeneration strategy. | |
| PEG/ | SLA & hydrogel | In vivo | Rabbit trochlea critical size osteochondral defects. | 52 weeks | The repaired subchondral bone formed from 16 to 52 weeks in a “flow like” manner from surrounding bone to the defect center gradually. | |
| PCL/HA | FDM | in vitro in vivo | Bone marrow clots and BMSC from 30 female New Zealand white rabbits (5-6 months old). 60 Female nude mice (6-7 weeks old). | 4 weeks | Combination with MC is a highly efficient, reliable, and simple method that improves the biological performance of 3D PCL/HA scaffold. | |
| PCL | SLA | In vitro In vivo | Yorkshire pigs Supraperichondrial soft tissue flaps | 2 months | The histological evidence present that anatomically PCL based ear and nose resulted in the growth and maintenance of cartilage-like tissue. |
Comparison of various printed dental scaffolds in several in vitro and in vivo studies.
| PCL/HA (Infused SDF1- and BMP7-loaded collagen) | FDM | In vivo | 22 male (12-week-old) Sprague-Dawley rats: 1 Rat’s dorsum subcutaneous pouches for human mandibular molar scaffolds, 2 right mandibular central incisor for rat central incisor teeth | 9 weeks | A putative periodontal ligament and new bone regenerate at the interface of rat incisor scaffold with native alveolar bone by cell homing. | |
| PCL/HA 100 um, 300 um, 600 um. | FDM | In vitro In vivo | 1 DPSCs, 2 PDLSCs, 3 ABSCs. The dorsum’s mid-sagittal plane for 10-week-old immunodeficient mice (Harlan) | 4 weeks | DPSC-seeded multiphase scaffolds yield aligned PDL-like collagen fibers. The fibers inserted into bone sialoprotein-positive bone-like tissue and putative cementum matrix protein 1-positive/dentin sialophosphoprotein-positive dentin/cementum tissues. | |
| Alginate/ gelatin | Hydrogel extrusion | In vitro | hDPCs | Self-defined shaped 3D constructs are printed and achieve the cell viability of 87%. | ||
| PCL | FDM | In vitro | hDPCs | S3 weeks | The HT-PCL scaffold promotes cell migration and osteogenic differentiation. | |
| PCL | SLS | In vivo | Clinical case on a periodontitis patient‘s canine. | 13 months | The case demonstrated a 3-mm gain of clinical attachment and partial root coverage. However, the scaffold became exposed at the 13th month. | |
| PCL, collagen I gel | FDM | Ex vivo | PDLSCs seeded PCL was placed on tooth root surface defect. | 6 weeks | The new mineralized tissue layer seen in BMP-7 treated samples expressed cementum protein 1 (CEMP1) | |
| PEG, PCL, cell-laden Alginate | Hydrogel extrusion and FDM | In vitro | Multiple-layer bioprinting teeth was fabricated with a frame, two kinds of cell-laden hydrogel and a support. |
Figure 4Design and fabrication of anatomically shaped human and rat tooth scaffolds by 3D bioprinting.
Design and fabrication of anatomically shaped human and rat tooth scaffolds by 3D bioprinting. Anatomic shape of the rat mandibular central incisor (A) and human mandibular first molar (B) were used for 3D reconstruction and bioprinting of a hybrid scaffold of poly- ϵ-caprolactone and hydroxyapatite, with 200-µm microstrands and interconnecting microchannels (diam., 200 µm), which serve as conduits for cell homing and angiogenesis (C, D). A blended cocktail of stromal-derived factor-1 (100 ng/mL) and bone morphogenetic protein-7 (100 ng/mL) was delivered in 2 mg/mL neutralized type I collagen solution and infused in scaffold microchannels for rat incisor scaffold (E) and human molar scaffold (F), followed by gelation. (G) In human mandibular molar scaffolds, cells populated scaffold microchannels without growthfactor delivery. (H) Combined SDF1 and BMP7 delivery induced substantial cell homing into microchannels. (I) Combined SDF1 and BMP7 delivery homed significantly more cells into the microchannels than without growth-factor delivery (p < 0.01; N = 11). (J) Combined SDF1 and BMP7 delivery elaborated significantly more blood vessels than without growth-factor delivery (p < 0.05; N = 11). (K, L) Mineral tissue in isolated areas in microchannels adjacent to blood vessels and abundant cells, and confirmed by von Kossa staining. (M) Tissue sections from coronal, middle, and two root portions of human molar scaffolds were quantified for cell density and angiogenesis. s, scaffold; GF, growth factor(s). Scale: 100 µm. © SAGE Publications Kim et al. (2010).